Do you want to read an article? Please log in or register.
Model-based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus
Type 1 Diabetes
Related content
COMMENTED
Type 1 DiabetesGlycemic Control
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
Diabetes Care.
Dandona P, Mathieu C, Phillip M, Hansen L, Tschöpe D, Thorén F, Xu J, Langkilde AM; DEPICT-1 Investigators
doi: 10.2337/dc18-1087.
Pediatric Diabetes
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study
J Diabetes Complications.
d'Annunzio G, Beccaria A, Pistorio A, Verrina E, Minuto N, Pontremoli R, La Valle A, Maghnie M
doi: 10.1016/j.jdiacomp.
COMMENTED
Type 1 Diabetes
A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Tran-Duy A, Knight J, Palmer AJ, Petrie D, Lung TWC, Herman WH, Eliasson B, Svensson AM, Clarke PM
doi: 10.2337/dc19-2249.
COMMENTED
Diabetes - GeneralType 2 DiabetesGlycemic Control
A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT-R Study
Diabetes Obes Metab.
Scott R, Morgan J, Zimmer Z, Lam RLH, O'Neill EA, Kaufman KD, Engel SS, Raji A
doi: 10.1111/dom.13473.
Type 1 Diabetes
Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2
Diabetes Care.
Mathieu C, Dandona P, Phillip M, Oron T, Lind M, Hansen L, Thorén F, Xu J, Langkilde AM; DEPICT-1 and DEPICT-2 Investigators
doi: 10.2337/dc18-1983.
COMMENTED
Diabetic Complications
The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control
Diabetes Res Clin Pract.
Hatz K, Minder AE, Lehmann R, Drescher T, Gerendas B, Schmidt-Erfurth U, Kaider A, Pruente C, Zulewski H
doi: 10.1016/j.diabres.
COMMENTED
Type 1 Diabetes
Pancreas Pathology of Latent Autoimmune Diabetes in Adults (LADA) in Patients and in a LADA Rat Model Compared to Type 1 Diabetes Mellitus
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes.
Jörns A J A, Wedekind D W D, Jähne J J J, Lenzen S L S
doi: 10.2337/db19-0865.
COMMENTED
Diabetes - General
Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus
Ann Intern Med.
Roglic G, Norris SL
doi: 10.7326/M18-1149.
Diabetes - GeneralType 1 DiabetesGlycemic Control
Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm
Diabetes Technol Ther.
Buckingham BA, Forlenza GP, Pinsker JE, Christiansen MP, Wadwa RP, Schneider J, Peyser TA, Dassau E, Lee JB, O'Connor J, Layne JE, Ly TT
doi: 10.1089/dia.2017.0346.